Strowd, Roy E <br/><br/>
The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.  [electronic resource] 

 -  Journal of neuro-oncology  Mar 2016 
 - 165-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-015-2028-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Astrocytoma--drug therapy<br/>Brain Neoplasms--drug therapy<br/>Carmustine--administration & dosage<br/>Dacarbazine--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lomustine--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Procarbazine--administration & dosage<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Temozolomide<br/>Vincristine--administration & dosage